These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 26334163)

  • 1. The social history of ISIS-2: trial and tribulation.
    Keating C
    Lancet; 2015 Aug; 386(9994):e2-3. PubMed ID: 26334163
    [No Abstract]   [Full Text] [Related]  

  • 2. The social history of ISIS-2: triumph and the path not taken.
    Keating C
    Lancet; 2015 Aug; 386(9994):e4-5. PubMed ID: 26334164
    [No Abstract]   [Full Text] [Related]  

  • 3. The social history of ISIS-2: the early history.
    Keating C
    Lancet; 2015 Aug; 386(9994):646-7. PubMed ID: 26334149
    [No Abstract]   [Full Text] [Related]  

  • 4. ISIS and the emergence of large, simple trials.
    Altman DG
    Lancet; 2015 Aug; 386(9994):636-7. PubMed ID: 26334142
    [No Abstract]   [Full Text] [Related]  

  • 5. ISIS 3: the last word on thrombolysis?
    Cobbe S
    BMJ; 1992 Jun; 304(6840):1454-5. PubMed ID: 1489396
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effects of thrombolytic treatments on the mortality of myocardial infarction. Characteristics of large-scale trials, main results].
    Slama M; Cohen-Solal A; Spriet A
    Arch Mal Coeur Vaiss; 1989 Oct; 82 Spec No 3():27-33. PubMed ID: 2512885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aspirin augmentation of the efficacy of thrombolysis.
    O'Donnell CJ; Jonas MA; Hennekens CH
    Coron Artery Dis; 1995 Dec; 6(12):936-9. PubMed ID: 8723015
    [No Abstract]   [Full Text] [Related]  

  • 8. Antiplatelet and antithrombin therapy.
    Fernández-Ortiz A; Jang IK; Fuster V
    Coron Artery Dis; 1994 Apr; 5(4):297-305. PubMed ID: 8044341
    [No Abstract]   [Full Text] [Related]  

  • 9. [ISIS-2--a study of patients with myocardial infarction. A combination of streptokinase and acetylsalicylic acid diminishes mortality risk, reinfarction and stroke].
    Wilhelmsen L
    Lakartidningen; 1988 Aug; 85(35):2759-64. PubMed ID: 3047513
    [No Abstract]   [Full Text] [Related]  

  • 10. Aspirin, heparin, and fibrinolytic therapy in suspected acute myocardial infarction.
    Collins R; Peto R; Baigent C; Sleight P
    N Engl J Med; 1997 Mar; 336(12):847-60. PubMed ID: 9062095
    [No Abstract]   [Full Text] [Related]  

  • 11. Streptokinase plus aspirin does the trick: ISIS-3.
    Lancet; 1992 Mar; 339(8796):780-1. PubMed ID: 1347807
    [No Abstract]   [Full Text] [Related]  

  • 12. Thrombolytic therapy for acute myocardial infarction: where are we now? Where should we go?
    White HD
    Chin Med J (Engl); 1995 Jun; 108(6):462-5. PubMed ID: 7555259
    [No Abstract]   [Full Text] [Related]  

  • 13. [Fibrinolysis in myocardial infarction with EKG elevation. Optimization of myocardial reperfusion by treatment with antithrombotic agents].
    Jaïs C; Coste P; Labèque JN; Perron JM; Lafitte S; Zabsonré P; Roudaut R
    Arch Mal Coeur Vaiss; 2001 Nov; 94(11 Suppl):1259-66. PubMed ID: 11794967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aspirin after thrombolysis for MI.
    Seaton TL
    J Fam Pract; 1997 Mar; 44(3):249-50. PubMed ID: 9071241
    [No Abstract]   [Full Text] [Related]  

  • 15. Randomized comparison of a novel anticoagulant, vasoflux, and heparin as adjunctive therapy to streptokinase for acute myocardial infarction: results of the VITAL study (Vasoflux International Trial for Acute Myocardial Infarction Lysis).
    Peters RJ; Spickler W; Théroux P; White H; Gibson M; Molhoek PG; Anderson HV; Weitz JI; Hirsh J; Weaver WD
    Am Heart J; 2001 Aug; 142(2):237-43. PubMed ID: 11479461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Intracoronary thrombolysis using streptokinase in acute myocardial infarction. Pilot study of 12 cases].
    Andrés P; Velasco F; Torres A; Suárez de Lezo J; Vallés F; Martín N; Alvarez F; Montero JA; Concha M
    Sangre (Barc); 1984; 29(3):233-43. PubMed ID: 6484775
    [No Abstract]   [Full Text] [Related]  

  • 17. Randomized factorial trial of high-dose intravenous streptokinase, of oral aspirin and of intravenous heparin in acute myocardial infarction. ISIS (International Studies of Infarct Survival) pilot study.
    Eur Heart J; 1987 Jun; 8(6):634-42. PubMed ID: 2887430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Fibrinolysis therapy using APSAC in acute myocardial infarct].
    Hochrein H
    Dtsch Med Wochenschr; 1990 Jun; 115(25):999. PubMed ID: 2193790
    [No Abstract]   [Full Text] [Related]  

  • 19. Is ticlopidine more effective than aspirin in preventing adverse cardiovascular events after myocardial infarction (MI)?
    Olson J; Huntington J
    J Fam Pract; 2001 Jul; 50(7):623. PubMed ID: 11485713
    [No Abstract]   [Full Text] [Related]  

  • 20. [Aspirin and heparin in the fibrinolytic treatment of acute myocardial infarction].
    López Bescós L
    Rev Esp Cardiol; 1992; 45 Suppl 2():21-8. PubMed ID: 1475505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.